|
ABL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78473999999929E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.14970000000215E-05 |
| Normal-vs-Stage2 |
1.262230E-03 |
| Normal-vs-Stage3 |
1.55800999999123E-05 |
| Normal-vs-Stage4 |
7.85600000052789E-07 |
| Stage1-vs-Stage2 |
9.282600E-01 |
| Stage1-vs-Stage3 |
1.921590E-01 |
| Stage1-vs-Stage4 |
2.517700E-02 |
| Stage2-vs-Stage3 |
3.707800E-01 |
| Stage2-vs-Stage4 |
9.459700E-02 |
| Stage3-vs-Stage4 |
2.799400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80448000000055E-05 |
| Normal-vs-AfricanAmerican |
4.242200E-02 |
| Normal-vs-Asian |
1.080910E-03 |
| Caucasian-vs-AfricanAmerican |
1.901580E-01 |
| Caucasian-vs-Asian |
2.818800E-01 |
| AfricanAmerican-vs-Asian |
6.237600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.51489999997445E-06 |
| Normal-vs-Female |
3.56000000000245E-05 |
| Male-vs-Female |
2.904400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.353010E-04 |
| Normal-vs-Age(41-60Yrs) |
5.613399999993E-05 |
| Normal-vs-Age(61-80Yrs) |
2.95800000049695E-07 |
| Normal-vs-Age(81-100Yrs) |
2.746300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.567400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.247740E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.096400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.436500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.045800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.252200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.220400E-03 |
| Classical-VS-Follicular |
7.668300E-02 |
| Classical-VS-Other |
7.157800E-01 |
| Classical-VS-Normal |
2.000200E-04 |
| Tall-VS-Follicular |
1.504830E-01 |
| Tall-VS-Other |
2.890600E-01 |
| Tall-VS-Normal |
3.89580000037526E-07 |
| Follicular-VS-Other |
8.319200E-01 |
| Follicular-VS-Normal |
2.06489999999837E-05 |
| Other-VS-Normal |
7.760400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22420000000056E-05 |
| Normal-vs-N1 |
3.56320000000077E-05 |
| N0-vs-N1 |
4.280000E-01 |
|
|
